Osaic Holdings’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125K | Sell |
127,220
-36,528
| -22% | -$35.9K | ﹤0.01% | 3987 |
|
|
2025
Q1 | $164K | Buy |
163,748
+36,528
| +29% | +$36.5K | ﹤0.01% | 3791 |
|
|
2024
Q4 | $116K | Buy |
127,220
+4,800
| +4% | +$4.37K | ﹤0.01% | 4056 |
|
|
2024
Q3 | $184K | Buy |
122,420
+10,000
| +9% | +$15K | ﹤0.01% | 3717 |
|
|
2024
Q2 | $78.8K | Sell |
112,420
-1,390
| -1% | -$974 | ﹤0.01% | 4310 |
|
|
2024
Q1 | $108K | Buy |
113,810
+1,100
| +1% | +$1.05K | ﹤0.01% | 4185 |
|
|
2023
Q4 | $125K | Sell |
112,710
-72,572
| -39% | -$80.6K | ﹤0.01% | 4268 |
|
|
2023
Q3 | $348K | Buy |
185,282
+106,873
| +136% | +$201K | ﹤0.01% | 3557 |
|
|
2023
Q2 | $281K | Buy |
78,409
+153
| +0.2% | +$549 | ﹤0.01% | 3626 |
|
|
2023
Q1 | $264K | Buy |
78,256
+2,529
| +3% | +$8.52K | ﹤0.01% | 3648 |
|
|
2022
Q4 | $118K | Buy |
75,727
+960
| +1% | +$1.49K | ﹤0.01% | 4299 |
|
|
2022
Q3 | $101K | Sell |
74,767
-1,100
| -1% | -$1.49K | ﹤0.01% | 4363 |
|
|
2022
Q2 | $166K | Buy |
75,867
+932
| +1% | +$2.04K | ﹤0.01% | 3965 |
|
|
2022
Q1 | $1.54M | Buy |
74,935
+185
| +0.2% | +$3.8K | ﹤0.01% | 2159 |
|
|
2021
Q4 | $314K | Sell |
74,750
-1,808
| -2% | -$7.6K | ﹤0.01% | 3517 |
|
|
2021
Q3 | $623K | Sell |
76,558
-1,192
| -2% | -$9.7K | ﹤0.01% | 2810 |
|
|
2021
Q2 | $588K | Buy |
77,750
+4,200
| +6% | +$31.8K | ﹤0.01% | 2846 |
|
|
2021
Q1 | $639K | Sell |
73,550
-850
| -1% | -$7.39K | ﹤0.01% | 2626 |
|
|
2020
Q4 | $594K | Buy |
74,400
+20,390
| +38% | +$163K | ﹤0.01% | 2486 |
|
|
2020
Q3 | $431K | Buy |
54,010
+15,450
| +40% | +$123K | ﹤0.01% | 2563 |
|
|
2020
Q2 | $382K | Sell |
38,560
-5,420
| -12% | -$53.7K | ﹤0.01% | 2568 |
|
|
2020
Q1 | $281K | Buy |
+43,980
| New | +$281K | ﹤0.01% | 2579 |
|